TY - JOUR
T1 - Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer
T2 - an umbrella review
AU - Rammant, Elke
AU - Van Wilder, Lisa
AU - Van Hemelrijck, Mieke
AU - Pauwels, Nele S.
AU - Decaestecker, Karel
AU - Van Praet, Charles
AU - Bultijnck, Renée
AU - Ost, Piet
AU - Van Vaerenbergh, Thomas
AU - Verhaeghe, Sofie
AU - Van Hecke, Ann
AU - Fonteyne, Valérie
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Purpose: This umbrella review aims to evaluate the quality, summarize and compare the conclusions of systematic reviews investigating the impact of curative treatment options on health-related quality of life (HRQoL) in muscle-invasive bladder cancer (MIBC). Methods: The Cochrane Library, MEDLINE, Embase and Web of Science were searched independently by two authors from inception until 06 January 2020. Systematic reviews and meta-analyses assessing the impact of any curative treatment option on HRQol in MIBC patients were eligible. Risk of bias was assessed using the AMSTAR 2 tool. Results: Thirty-two reviews were included. Robot-assisted RC with extracorporeal urinary diversion and open RC have similar HRQoL (n = 10). Evidence for pelvic organ-sparing RC was too limited (n = 2). Patients with a neobladder showed better overall and physical HRQoL outcomes, but worse urinary function in comparison with ileal conduit (n = 17). Bladder-preserving radiochemotherapy showed slightly better urinary and sexual but worse gastro-intestinal HRQoL outcomes in comparison with RC patients (n = 6). Quality of the reviews was low in more than 50% of the available reviews and most of the studies included in the reviews were nonrandomized studies. Conclusion: This umbrella review gives a comprehensive overview of the available evidence to date.
AB - Purpose: This umbrella review aims to evaluate the quality, summarize and compare the conclusions of systematic reviews investigating the impact of curative treatment options on health-related quality of life (HRQoL) in muscle-invasive bladder cancer (MIBC). Methods: The Cochrane Library, MEDLINE, Embase and Web of Science were searched independently by two authors from inception until 06 January 2020. Systematic reviews and meta-analyses assessing the impact of any curative treatment option on HRQol in MIBC patients were eligible. Risk of bias was assessed using the AMSTAR 2 tool. Results: Thirty-two reviews were included. Robot-assisted RC with extracorporeal urinary diversion and open RC have similar HRQoL (n = 10). Evidence for pelvic organ-sparing RC was too limited (n = 2). Patients with a neobladder showed better overall and physical HRQoL outcomes, but worse urinary function in comparison with ileal conduit (n = 17). Bladder-preserving radiochemotherapy showed slightly better urinary and sexual but worse gastro-intestinal HRQoL outcomes in comparison with RC patients (n = 6). Quality of the reviews was low in more than 50% of the available reviews and most of the studies included in the reviews were nonrandomized studies. Conclusion: This umbrella review gives a comprehensive overview of the available evidence to date.
UR - http://www.scopus.com/inward/record.url?scp=85086002984&partnerID=8YFLogxK
U2 - 10.1007/s11136-020-02544-z
DO - 10.1007/s11136-020-02544-z
M3 - Review article
AN - SCOPUS:85086002984
SN - 0962-9343
VL - 29
SP - 2887
EP - 2910
JO - Quality of Life Research
JF - Quality of Life Research
IS - 11
ER -